纳米块介导的选择性性多治疗三阴性乳腺癌
Cuiyu Zhong1,2, Jie Li3, Suiping Liu1,4,5
1Breast Tumor Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China.
Theranostics
|June 7, 2023
概括
研究人员开发了一种纳米块策略,以减少三阴性乳腺癌 (TNBC) 治疗的类 (Olp) 毒性. 这种方法保护Olps,直到它们到达酸性瘤环境,从而使向癌细胞的破坏减少副作用.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 在瘤学瘤学.
背景情况:
- 广谱解性 (Olps) 显示出对三阴性乳腺癌 (TNBC) 治疗的前景.
- 由于显著的全身毒性,Olps的临床使用受到阻碍.
- 开发有针对性的输送系统对于提高Olp的有效性和安全性至关重要.
研究的目的:
- 为了设计一个纳米块介导的策略来选择性激活Olps.
- 为了减少Olps固有的毒性,同时保持其抗癌活性.
- 开发一种新的TNBC治疗方法,使用瘤酸度响应的Olp输送.
主要方法:
- 合成Olps与聚乙烯氧化物) -b-聚乙烯氧化物) 纳米粒子结合.
- 一种纳米阻断剂被确定可以降低Olp的溶血活性.
- 通过瘤酸度可切割键,Olps与纳米阻断剂联系在一起,形成选择性的RNolp.
主要成果:
- 纳米颗粒对合的Olps显著降低了溶血活性.
- 在生理pH (7.4) 时,RNolp保持稳定,活性最小.
- 在酸性瘤pH值 (6.8) 时,Olps被释放出来,对TNBC细胞表现出强大的膜解活性.
- 在小鼠中,RNolp表现出良好的耐受性,在TNBC模型中表现出显著的抗瘤疗效.
结论:
- 一个纳米块介导的策略有效地屏蔽了Olps,降低了毒性.
- 开发的RNolp系统提供瘤特异性激活,增强治疗潜力.
- 这种方法为TNBC选择性癌症治疗提供了一个有希望的策略.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Tumor Immunotherapy
575
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
575


